Australia Dermatological Drugs Market Size & Outlook
Australia dermatological drugs market, 2018-2030 (US$M)
Related Markets
Australia dermatological drugs market highlights
- The Australia dermatological drugs market generated a revenue of USD 261.7 million in 2024 and is expected to reach USD 519.1 million by 2030.
- The Australia market is expected to grow at a CAGR of 12.1% from 2025 to 2030.
- In terms of segment, psoriasis was the largest revenue generating therapy in 2024.
- Psoriasis is the most lucrative therapy segment registering the fastest growth during the forecast period.
Dermatological drugs market data book summary
| Market revenue in 2024 | USD 261.7 million |
| Market revenue in 2030 | USD 519.1 million |
| Growth rate | 12.1% (CAGR from 2025 to 2030) |
| Largest segment | Psoriasis |
| Fastest growing segment | Psoriasis |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Acne, Psoriasis, Rosacea, Alopecia |
Other key industry trends
- In terms of revenue, Australia accounted for 1.1% of the global dermatological drugs market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China dermatological drugs market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,268.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dermatological Drugs Market Scope
Dermatological Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia dermatological drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatological drugs market will help companies and investors design strategic landscapes.
Psoriasis was the largest segment with a revenue share of 40.35% in 2024. Horizon Databook has segmented the Australia dermatological drugs market based on acne, psoriasis, rosacea, alopecia covering the revenue growth of each sub-segment from 2018 to 2030.
Australia’s dermatological drugs market is experiencing steady growth, driven by the increasing prevalence of skin conditions such as acne, eczema, psoriasis, and alopecia areata. The demand for anti-aging and aesthetic dermatology treatments also contributes to market expansion.
Australia’s healthcare system and growing awareness of dermatological health play a significant role in supporting this growth. The adoption of advanced treatments, particularly biologics, has strengthened market dynamics, with pharmaceutical companies focusing on innovative solutions to address unmet medical needs.
Reasons to subscribe to Australia dermatological drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia dermatological drugs market databook
-
Our clientele includes a mix of dermatological drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia dermatological drugs market , including forecasts for subscribers. This country databook contains high-level insights into Australia dermatological drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia dermatological drugs market size, by indication, 2018-2030 (US$M)
Australia Dermatological Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
